Treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Treatment for hypertension was 39.8% in 2019. ▲ Rising
Treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of adults ages 30-79 with hypertension.
Analysis
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) recorded 39.8% for treatment for hypertension in 2019. That is the highest value across all 30 years on record.
Compared with earlier readings it is up 0.2% on the previous year and up 8.8% over ten years.
Over the whole period, treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) peaked at 39.8% in 2019 and was at its lowest, 21.1%, in 1990.
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 22nd of 43 groups on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), year by year
| Year | % of adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 21.1% | — |
| 1991 | 21.6% | +2.2% |
| 1992 | 22.1% | +2.4% |
| 1993 | 22.7% | +2.6% |
| 1994 | 23.2% | +2.5% |
| 1995 | 23.9% | +2.8% |
| 1996 | 24.5% | +2.6% |
| 1997 | 25.2% | +2.9% |
| 1998 | 26.0% | +3.1% |
| 1999 | 26.8% | +3.1% |
| 2000 | 27.7% | +3.3% |
| 2001 | 28.6% | +3.3% |
| 2002 | 29.6% | +3.5% |
| 2003 | 30.7% | +3.6% |
| 2004 | 31.8% | +3.7% |
| 2005 | 32.9% | +3.4% |
| 2006 | 33.9% | +3.3% |
| 2007 | 34.9% | +2.8% |
| 2008 | 35.8% | +2.6% |
| 2009 | 36.6% | +2.1% |
| 2010 | 37.3% | +1.9% |
| 2011 | 37.9% | +1.5% |
| 2012 | 38.4% | +1.3% |
| 2013 | 38.8% | +1.0% |
| 2014 | 39.1% | +0.8% |
| 2015 | 39.3% | +0.7% |
| 2016 | 39.6% | +0.6% |
| 2017 | 39.6% | +0.1% |
| 2018 | 39.7% | +0.2% |
| 2019 | 39.8% | +0.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 23.7% | 21.1% | 26.8% | 10 |
| 2000s | 32.2% | 27.7% | 36.6% | 10 |
| 2010s | 38.9% | 37.3% | 39.8% | 10 |
Countries ranked near Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
More health data for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 3.1 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0305 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 3.2 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0351 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 1.48 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0341 units per person (2025)
- Population ages 30-34, female, annual growth rate 0.471 % change on previous year (2025)
All data for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) →
Frequently asked questions
- What is treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- Treatment for hypertension in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) was 39.8% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension recorded in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- The highest recorded value was 39.8% in 2019.
- What is the lowest treatment for hypertension recorded in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- The lowest recorded value was 21.1% in 1990.
- How does Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank for treatment for hypertension?
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 22nd out of 43 groups with data for 2019.
- Is treatment for hypertension rising or falling in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- Over the last ten years it is up 8.8%. The long-run trend across the full record is rising.
- Where does this Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension (% of adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.